Nancy J. Bigley, Ph. D. Thesis DirectorALANOUD GHASSAN GHONAIM2022-06-012022-06-01https://drepo.sdl.edu.sa/handle/20.500.14154/57447the hypothesis of the study is that innate immunity interferons (type I and III IFNs) are beneficial therapeutics for SARS-CoV-2 infection, and type III IFNs maybe are more effective than type I IFNs, especially in the early stage of infection of covid-19.en